Earnings Feed
Start Free
$SLS·4

Galena Biopharma, Inc. · Jan 22, 9:14 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Jan 22, 2014

Insider Transaction Report

Form 4
Period: 2014-01-17
Galena Biopharma, Inc.GALE
KRIEGSMAN STEVEN A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2014-01-22$1.18/sh+200,000$236,000→ 205,000 total
  • Sale

    Common Stock

    2014-01-22$6.13/sh−250,000$1,532,500→ 5,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-17−200,000→ 0 total
    Exercise: $0.85From: 2011-09-27Exp: 2021-09-27→ Common Stock (200,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-22−50,000→ 0 total
    Exercise: $0.72From: 2013-01-12Exp: 2022-01-12→ Common Stock (50,000 underlying)
  • Sale

    Common Stock

    2014-01-17$7.00/sh−200,000$1,400,000→ 5,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-17$0.85/sh+200,000$170,000→ 205,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-22$0.72/sh+50,000$36,000→ 255,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-22−200,000→ 0 total
    Exercise: $1.18From: 2011-03-25Exp: 2021-03-24→ Common Stock (200,000 underlying)

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT